°×С½ãÂÛ̳

XClose

°×С½ãÂÛ̳ Module Catalogue

Home
Menu

Neuropharmacology (PHAR0010)

Key information

Faculty
Faculty of Life Sciences
Teaching department
Division of Biosciences
Credit value
15
Restrictions
Prerequisites for °×С½ãÂÛ̳ undergraduates are: either 2nd year Pharmacology (PHAR0003/4/7/9) or MBBS years 1&2.
Timetable

Alternative credit options

There are no alternative credit options available for this module.

Description

In recent years many developments, such as the use of levo dopa in Parkinsonism, the manipulation of excitation in epilepsy and the discovery of endogenous opioids, have brought basic neuropharmacology and the successful treatment of disorders of the C.N.S. much closer together. It is likely that future prospects for drug therapy in neurology and psychiatry will depend very much on a better understanding of neurotransmitter function and manipulation.Ìý

This neuropharmacology module tries to provide a basis for such an understanding. The evidence for different transmitters (from morphological, electrophysiological, pharmacological and biochemical studies) is evaluated so as to build up a picture of their pre- and post-synaptic actions and their interactions in specific pathways and brain areas. This knowledge is then applied to a consideration of various disease states and drug action. Special emphasis is given to neurotransmitter function and malfunction in epilepsy, Parkinsonism, memory, cell death and pain states and to the mode of action of drugs in these conditions.Ìý

Students will attend a comprehensive series of lectures on these issues given by experts in the field.Ìý

Indicative Lecture Topics (based on 2023/2024 syllabus)Ìý

  • Fundamentals of NeuropharmacologyÌý

  • Transmitter systems and their modulationÌý

  • Transmitter release mechanismsÌý

  • Neuropharmacological techniquesÌý

  • Glutamate receptors and fast transmissionÌý

  • Glutamate Receptors and diseaseÌý

  • Metabolic glutamate receptorsÌý

  • Neuropharmacology of memoryÌý

  • Atypical transmittersÌý

  • GABA-A Inhibition and epilepsyÌý

  • GABA-B and diseaseÌý

  • Cholinergic Transmission – Nicotinic aspectsÌý

  • Cholinergic transmission: Muscarinic aspectsÌý

  • ²Ñ´Ç²Ô´Ç²¹³¾¾±²Ô±ð²õÌý

  • Calcium channels and diseaseÌý

  • Alzheimer's diseaseÌý

  • Parkinson's diseaseÌý

  • Pain and analgesicsÌý

Module deliveries for 2024/25 academic year

Intended teaching term: Term 1 ÌýÌýÌý Postgraduate (FHEQ Level 7)

Teaching and assessment

Mode of study
In person
Methods of assessment
80% Exam
20% Viva or oral presentation
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
4
Module leader
Dr Stephanie Koch
Who to contact for more information
s.koch@ucl.ac.uk

Intended teaching term: Term 1 ÌýÌýÌý Undergraduate (FHEQ Level 6)

Teaching and assessment

Mode of study
In person
Methods of assessment
80% Exam
20% Coursework
Mark scheme
Numeric Marks

The methods of assessment for affiliate students may be different to those indicated above. Please contact the department for more information.

Other information

Number of students on module in previous year
72
Module leader
Dr Stephanie Koch
Who to contact for more information
s.koch@ucl.ac.uk

Intended teaching term: Term 1 ÌýÌýÌý Undergraduate (FHEQ Level 7)

Teaching and assessment

Mode of study
In person
Methods of assessment
80% Exam
20% Viva or oral presentation
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
5
Module leader
Dr Stephanie Koch
Who to contact for more information
s.koch@ucl.ac.uk

Last updated

This module description was last updated on 8th April 2024.

Ìý